Naloxone


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000787 Angina Pectoris PMID:3511346
MESH:D001049 Apnea PMID:4057297
MESH:D001281 Atrial Fibrillation PMID:19378534
MESH:D001714 Bipolar Disorder PMID:12575238
MESH:D001763 Blepharoptosis PMID:11498714
MESH:D001919 Bradycardia PMID:1335070; PMID:2339451; PMID:6093200; PMID:7862711
MESH:D002375 Catalepsy PMID:8535858
MESH:D003244 Consciousness Disorders PMID:2436013
MESH:D003967 Diarrhea PMID:11498714
MESH:D004244 Dizziness PMID:11547785
MESH:D004829 Epilepsy, Generalized PMID:8780117
MESH:D004830 Epilepsy, Tonic-Clonic PMID:10852088; PMID:2914040
MESH:D004831 Epilepsies, Myoclonic PMID:8780117
MESH:D005767 Gastrointestinal Diseases PMID:15167188
MESH:D006099 Granuloma PMID:16931994
MESH:D006212 Hallucinations PMID:2436013; PMID:9799024
MESH:D006323 Heart Arrest PMID:11971848; PMID:18509674; PMID:8699555
MESH:D006331 Heart Diseases PMID:7078751
MESH:D006930 Hyperalgesia PMID:10195313; PMID:10910860; PMID:11429366; PMID:14581115; PMID:17692296; PMID:28434951; PMID:3475494; PMID:561998; PMID:6620740; PMID:9539228
MESH:D006940 Hyperemia PMID:4058695
MESH:D006948 Hyperkinesis PMID:15936807
MESH:D006973 Hypertension PMID:2339451; PMID:2468958; PMID:2931022; PMID:3559705; PMID:3827314; PMID:4406136; PMID:574740; PMID:6291802; PMID:6638430; PMID:7212343
MESH:D007022 Hypotension PMID:11547785; PMID:2339451; PMID:2372173
MESH:D009021 Morphine Dependence PMID:11735362
MESH:D009069 Movement Disorders PMID:12373562
MESH:D009127 Muscle Rigidity PMID:274086
MESH:D009128 Muscle Spasticity PMID:17684894
MESH:D009203 Myocardial Infarction PMID:10852088
MESH:D009207 Myoclonus PMID:2339451
MESH:D009325 Nausea PMID:2339451; PMID:3021082
MESH:D009357 Neonatal Abstinence Syndrome PMID:2567922
MESH:D009422 Nervous System Diseases PMID:12030189
MESH:D010146 Pain PMID:12237198; PMID:14581115; PMID:17964860; PMID:6262228
MESH:D010149 Pain, Postoperative PMID:28434951
MESH:D010292 Paresthesia PMID:9799024
MESH:D011596 Psychomotor Disorders PMID:10568848
MESH:D011654 Pulmonary Edema PMID:2774157; PMID:8699555
MESH:D012640 Seizures PMID:1794335; PMID:18292293; PMID:1946581; PMID:221844; PMID:2339451; PMID:2372173; PMID:666036; PMID:7172122; PMID:8699555
MESH:D012735 Sexual Dysfunction, Physiological PMID:3021082
MESH:D013375 Substance Withdrawal Syndrome PMID:10330710; PMID:10448923; PMID:10495006; PMID:10680585; PMID:10910860; PMID:11027224; PMID:11090647; PMID:11359533; PMID:11404432; PMID:11413242; PMID:11483380; PMID:11498714; PMID:11547785; PMID:11817512; PMID:11849821; PMID:11976266; PMID:12062589; PMID:12065195; PMID:12154229; PMID:12431775; PMID:12567959; PMID:12845923; PMID:12911621; PMID:12921910; PMID:1327709; PMID:14598306; PMID:15083563; PMID:15164157; PMID:15196791; PMID:15196794; PMID:1533339; PMID:15541421; PMID:15542745; PMID:15561466; PMID:15595686; PMID:16382193; PMID:16448827; PMID:16470403; PMID:16575353; PMID:16914643; PMID:17549049; PMID:1786813; PMID:17958328; PMID:17989510; PMID:18082850; PMID:18469544; PMID:18705754; PMID:18834357; PMID:18840427; PMID:19067385; PMID:19489750; PMID:19660510; PMID:19751225; PMID:20203187; PMID:2027527; PMID:20434889; PMID:20519536; PMID:20719804; PMID:21270789; PMID:21285874; PMID:21645529; PMID:225122; PMID:22590628; PMID:2415332; PMID:2436013; PMID:24398105; PMID:2449543; PMID:2449617; PMID:25308750; PMID:25582704; PMID:2569624; PMID:26554626; PMID:2771062; PMID:2846107; PMID:30504240; PMID:3083461; PMID:3101100; PMID:3136361; PMID:3168761; PMID:3241876; PMID:3343705; PMID:3471262; PMID:3539055; PMID:3666080; PMID:3720824; PMID:3945661; PMID:567958; PMID:6184732; PMID:6258694; PMID:6300721; PMID:6676478; PMID:6818593; PMID:7190475; PMID:7201058; PMID:7400953; PMID:7692360; PMID:7734084; PMID:7791109; PMID:7869613; PMID:7896067; PMID:8090802; PMID:8450704; PMID:8692292; PMID:8704441; PMID:8747757; PMID:8829152; PMID:8870037; PMID:8996817; PMID:9164573; PMID:9263765; PMID:9274799; PMID:9495411; PMID:9496717; PMID:9523765; PMID:9734704; PMID:9838021; PMID:988178
MESH:D013610 Tachycardia PMID:15167188
MESH:D014202 Tremor PMID:11498714; PMID:12845923; PMID:15167188; PMID:20203187; PMID:3021082
MESH:D014555 Urination Disorders PMID:3942028
MESH:D014839 Vomiting PMID:11547785; PMID:17156855; PMID:2339451; PMID:2372173; PMID:7711465
MESH:D015431 Weight Loss PMID:25582704; PMID:3157294
MESH:D015746 Abdominal Pain PMID:12845923
MESH:D015877 Miosis PMID:1526766
MESH:D016055 Urinary Retention PMID:6859567
MESH:D016584 Panic Disorder PMID:17156855
MESH:D017180 Tachycardia, Ventricular PMID:16054011
MESH:D018880 Atrial Premature Complexes PMID:574740

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.